Molnupiravir gains outweigh risks: Experts counter ICMR

Leading Covid-19 task force members and health experts treating coronavirus patients across the country said on Monday that the Covid antiviral drug molnupiravir is reducing hospitalisation by 30-50 %, as well as the severity of the disease.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3ncSMdm